Middle East Healthcare Company (TADAWUL:4009)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
30.28
+0.18 (0.60%)
Jul 23, 2026, 3:18 PM AST

TADAWUL:4009 Financials Overview

Millions SAR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,1343,1032,8832,6532,1521,873
Revenue Growth
7.08%7.63%8.66%23.30%14.90%6.97%
Gross Profit
1,1201,1461,1021,004671.99595.14
Operating Income
359.36387.3440.93323.97140.3454.24
Net Income
167.45301.8828217.0475.1817.2
Earnings Per Share
1.823.283.060.190.820.19
EPS Growth
-57.94%7.05%1555.10%-77.34%337.08%-79.02%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
In Patient Services
1,7401,7231,6281,5451,2391,098
Outpatient Services
980.91968.93852.68740.19587.88491.24
Pharmacy Sales
407.47407.75393.25361.06313.54265.42
Others
6.043.288.776.5911.3417.66
Total
3,1343,1032,8832,6532,1521,873

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
24.126.352.2844.4215.628.13
Total Debt
2,4612,5442,4662,4852,2401,967
Net Cash (Debt)
-2,437-2,517-2,414-2,441-2,225-1,939
Net Cash Growth
------
Net Cash Per Share
-26.48-27.35-26.22-26.52-24.17-21.06

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
535.47544.6766191.0876.0276.62
Capital Expenditures
-552.74-455.16-470.82-229.61-249.52-416.56
Free Cash Flow
-17.2789.44295.18-38.53-173.5-339.94
Free Cash Flow Growth
--69.70%----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
35.75%36.94%38.23%37.83%31.23%31.78%
Operating Margin
11.46%12.48%15.29%12.21%6.52%2.90%
Pretax Margin
5.98%10.49%10.76%7.20%3.77%1.03%
Profit Margin
5.34%9.73%9.78%0.64%3.49%0.92%
FCF Margin
-0.55%2.88%10.24%-1.45%-8.06%-18.15%

Dividends

Fiscal YearCurrentFY 2025FY 2024
Period EndingJul '26 Dec '25 Dec '24
Dividend Per Share
0.5000.5000.500
Dividend Per Share Growth
0%0%-
Dividend Yield
1.65%1.56%0.75%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.649.9322.42476.9931.16169.35
Forward PE
17.4410.5222.9632.6224.5127.34
P/FCF Ratio
-33.5121.42---
PS Ratio
0.890.972.193.061.091.56